Načítá se...
Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma
[Image: see text] Multiple myeloma remains an incurable malignancy of plasma cells. Novel therapies, notably proteasome inhibitors and immunomodulatory drugs, have improved the survival of multiple myeloma patients; however, patients either present with, or develop resistance to, these therapies. Re...
Uloženo v:
| Vydáno v: | ACS Pharmacol Transl Sci |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American
Chemical Society
2021
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204322/ https://ncbi.nlm.nih.gov/pubmed/34151200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.1c00074 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|